Cannabis
Radient Announces Update on Trading Reinstatement
Edmonton, Alberta–(Newsfile Corp. – April 3, 2023) – Radient Technologies Inc. (TSXV: RTI) (OTCQX: RDDTF) (“Radient” or the “Company“) is pleased to announce that the Company has applied to the TSX Venture Exchange (the “TSXV“) to reinstate trading of its common shares and is preparing responses to the TSXV’s enquiries and compiling the requisite materials.
As previously announced on March 30, 2023, the Alberta Securities Commission granted Radient a revocation order respecting a failure-to-file cease trade order (“FFCTO“) that has been in effect since March 7, 2023. The revocation order also evidences the decision of the Ontario Securities Commission. The issuance of the revocation order follows the filing by Radient of its interim financial statements for the nine-month period ended December 31, 2022, and the related Management’s Discussion and Analysis and Certifications on March 22, 2023. On March 8, 2023, following the issuance of the FFCTO, the TSXV suspended trading of the Company’s common shares.
The Company would like to thank its shareholders and supporters for their patience at this time and confirms that it will endeavour to issue regular press releases to keep investors apprised of the situation, including of any anticipated trading resumption timeline.
About Radient
Radient is a commercial manufacturer of diverse, novel and high-quality cannabis extracts and packaged products. Radient develops specialty products and ingredients that contain a broad range of cannabinoid and terpene profiles while meeting the highest standards of quality and safety. Radient is focused on innovation with expertise in formulations and technologies offering unique solutions in the cannabis and wellness space. Please visit www.radientinc.com for more information.
For more information, please contact:
Steven Splinter, CEO & Director
[email protected]
Ph: 780 465 1318
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/161168
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Hemp, Inc. Welcomes USDA Approval of GMO Hemp Strain – A Step Forward in Cannabis Biotechnology
-
Cannabis2 weeks ago
Right On Brands, Inc. Continues Rollout, Announces 13th Store Opening
-
Cannabis2 weeks ago
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
-
Cannabis2 weeks ago
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
-
Cannabis2 weeks ago
Geopulse Exploration, Inc. Acquires 50% of ATC Services
-
Cannabis2 weeks ago
Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results
-
transfer1 week ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands